Mark Christopher Capone

Companies

• SERA PROGNOSTICS, INC.Board member Jul 1, 2026 to now¹
• MESA LABORATORIES INC /CO/Board member Feb 16, 2024 to now²
• DermTech, Inc.Board member Jul 20, 2022 to Jun 5, 2023³
• Myriad GeneticsPresident Mar 5, 2010 to Oct 1, 2019⁴
• Myriad GeneticsChief operating officer Feb 8, 2006 to Feb 19, 2010⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• MLMESA LABORATORIES INC /CO/ MLAB6,213 shares⁶$793.6K at $127.74Aug 15, 2026
• SPSERA PROGNOSTICS, INC. SERA44,379 shares⁷$90.5K at $2.04Jul 10, 2026
• DDermTech, Inc.82,054 shares⁸Jun 1, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 15, 2026Exercised options 2,784 shares of MESA LABORATORIES INC /CO/⁶
• Jul 10, 2026Granted 1,975 shares of SERA PROGNOSTICS, INC.⁷
• Jul 10, 2026Granted 42,404 shares of SERA PROGNOSTICS, INC.⁷
• Mar 10, 2026Bought 1,301 shares at $76.35 of MESA LABORATORIES INC /CO/⁹
• Aug 15, 2025Exercised options 1,404 shares of MESA LABORATORIES INC /CO/¹⁰
• Aug 15, 2024Exercised options 724 shares of MESA LABORATORIES INC /CO/¹¹
• Jun 1, 2023Granted 35,714 shares of DermTech, Inc.⁸
• Jul 18, 2022Granted 19,860 shares of DermTech, Inc.¹²
• Jul 18, 2022Granted 26,480 shares of DermTech, Inc.¹²